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Precipitation of fibrinogen is a newly described property of streptococcal M 
protein (1). Heretofore the only known function of M protein has been related 
to determining virulence of Group A streptococci by impeding phagocytosis (2). 
Small amounts of M  protein have been injected into normal mice and rabbits 
by the  usual parenteral  routes without evidence of toxicity (3,  4).  In man, 
subcutaneous or intramuscular injections of M  protein  or streptococcal  cell 
walls containing M  protein  have been innocuous  (5).  The present  report  is 
concerned with the production in mice and rats of renal lesions following intra- 
venous injections of larger quantities of M protein. 
Production of serum sickness nephritis by intravenous injection of soluble 
antigen-antibody complexes in several species has been thoroughly described 
(6).  Initiation of tissue damage in this disease appears to be the localization of 
preformed antigen-antibody complexes in the glomerttlar capillary bed. Indeed, 
several colloidal materials tend to localize in the renal glomerular capillary bed, 
a localization which is facilitated by blockade of the reticuloendothelial system 
(7). To produce renal lesions with antigen-antibody complexes, large amounts 
are necessary. In the mouse, McCluskey and Benacerraf used approximately 8 
mg  of  antiovalbumin antibody per  25  gin mouse;  amounts  of  rabbit  anti- 
bovine serum albumin antibody used by Germuth to produce the pathological 
changes of serum sickness in the rabbit were of the same order of magnitude (8). 
Milligram quantifies of M  protein,  injected into  mice and rats,  were cal- 
culated to produce M-fibrinogen complexes in vivo comparable to that amount 
of  antigen-antibody complexes  necessary  to  produce  nephritis.  The  lesions 
produced are described herein. 
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Material and Methods 
Streptococcal M  Protein.--Partially purified  M  protein was  prepared  by  the  method  of 
Lancefield and  Perlmann  (9). Two  Type 1 and one Type 12 streptococal strains were used. 
T1/155/4,1 a Type 1 strain, was stored in the lyophilized state. For the purpose of preparing M 
protein this strain was passed serially through 8 mice, after which 10 to 50 organisms consist- 
ently killed the mice. Organisms were grown in Todd-Hewitt broth at 37  ° C in 4-liter lots, and 
collected in either a Sharpies or bucket-type centrifuge. The cells were washed three times with 
saline and then pooled for M  protein extraction. Type  12, strain SF422 was similarly mouse 
passaged, grown, and collected for M  protein extraction. T1/2278, a obtained as phenolized 
Type I bacterial cells, were washed five times in saline prior to M protein extraction. 
Boundary electrophoresis of these materials revealed single peaks with sufficient boundary 
spreading to suggest some heterogeneity. M  proteins reacted with type-specific antisera,  4 at 
concentrations as low as 5 #g/ml and were in all respects similar to preparations described by 
the earlier workers. Further purification was not attempted. 
Animal Inoculation.--Male  Swiss white mice weighing approximately 25 gm were injected 
intravenously with 0.5 ml volumes of M  protein or human serum albumin  ~ (HSA) solution; 
amounts are described with individual experiments. Sprague-Dawley rats weighing 100 to 150 
gm were injected intravenously with M protein or HSA as described in the protocols. 
Antisera.--Anti-Type 1 M protein antisera were obtained from 2 to 3 kg New Zealand white 
rabbits immunized in the following manner: a saline solution of M protein containing 10 mg/ml 
was emulsified with an equal volume of complete Freund's adjuvant (Difco Laboratories, Inc., 
Detroit). Rabbits were injected with 0.5 ml of emulsion into each of 4 sites in the axillae and 
groin areas. Two weeks later these injections were repeated.  Four weeks after onset of im- 
munization intradermal injections of 0.1 ml of a saline solution (10 mg/ml) of M protein into 
four sites on the back were performed every 3rd day for 4 injections. Animals were bled from 
the heart 9 days after the last injections; the serum was separated, dispensed in 2 ml amounts, 
and frozen at --20°C. Analysis of precipitation patterns obtained in agar by Ouchterlony tech- 
nique (10), revealed one strong and one weak precipitation line. A single absorption of serum 
with an equal volume of packed heterologous streptococcal cells (SF42) at 37°C for 1 hour and 
24 hours at 4°C, resulted in loss of the weaker precipitation line. Absorbed antiserum failed to 
precipitate in eapillary tubes (11) with potent acid extracts of types 3, 6, 12, 18, and 25 strep- 
tococci. 
Rabbit anti-mouse fibrinogen antibodies were prepared according to the method of Gitlin 
et al.  (12).  Three hundred mice were decapitated  and pooled blood collected with heparin 
(Organon, Inc., West Orange, New Jersey) in final concentration of 20 u.s.P, units/ml.  Plasma 
was separated immediately and Cohn fraction I  obtained by low temperature ethanol-water 
separation (13). Mouse fibrin was prepared from fraction I  (0.5 per cent) with bovine thrombin 
(0.1 unit/ml). Fibrin strands were wound around a glass rod as they formed. After 90 minutes 
the fibrin was stripped off a glass rod into a Waring blendor in which it was washed three times 
with 0.15 M NaC1,  then twice with distilled water, and then twice again with 0.15 ~  NaC1. 
Fibrin was then teased into very small particles and suspended in washed aluminum hydrox- 
ide, 25 mg fibrin per milliliter of suspension. Rabbits were injected weekly subcutaneously with 
25 mg of fibrin suspension distributed into four sites in the axillae and groin areas. After four 
injections the rabbits were rested for 3 weeks and then received two more weekly injections. 
1., Kindly obtained from Dr. R. C. Lance  field. 
a Obtained through the generosity of Merck, Sharp and Dohme Laboratories, West Point, 
Pennsylvania. 
Obtained from the Communicable Disease Center Laboratories, Atlanta, Georgia. 
Lot RLA 50B, provided by the American National Red Cross. m~-ED s.  KA~rOR  863 
Ten days after the last injection animals were bled by cardiac puncture and the serum sepa- 
rated, dispensed in 2 ml amounts, and frozen.  Precipitin analysis of the rabbit antisera per- 
formed in agar by double diffusion Ouchterlony technique against normal pooled mouse plasma 
revealed a strong fibrinogen-antifibrinogen  line, and four contaminating  precipitin lines. Rabbit 
antisera were absorbed with mouse serum as follows: normal pooled  mouse  serum  was  ly- 
ophilized and redissolved in water in concentration of 5 mg/ml. To 10 ml of rabbit antiserum 
was added 0.1 ml of the mouse serum solution. After incubation at 37°C for I hour and at 4°C 
overnight, the antiserum was centrifuged at 4000 g for 30 minutes in the cold and the supernate 
decanted. Successive increments of mouse serum solution were added in like manner to avoid 
antigen excess and the formation of soluble complexes of any of the contaminating serum pro- 
tein antigens. After 6 to 9 absorptions, the resulting rabbit antiserum failed to precipitate with 
further addition of mouse serum solution. Precipitin analysis of the absorbed antiserum versus 
mouse plasma revealed a strong fibrinogen-antifibrinogen  line with a faint contaminating line 
believed to represent plasminogen-antiplasminogen precipitate. Most plasminogen in plasma 
remains with the clot; little is left in serum. The failure to absorb antiplasminogen antibodies 
is likely to be due to absence or very low levels of plasminogen antigen in the absorbing mouse 
serum solution. 
Floursce~ Labeling  of A~iscra.--The globulin fractions of absorbed rabbit anti-Type 1 M 
protein antiserum and rabbit anti-mouse fibrinogen antiserum were prepared by precipitation 
with ammonium sulfate to a final concentration of 1.6 M. The precipitates were washed with 
2.0 M ammonium sulfate in distilled water, redissolved, and dialyzed versus 0.01 ~r phosphate 
buffer at pH 7.5. Labeling of globulin was carried out under conditions similar to those de- 
scribed by Goldstein et al.  (14), after initial purification by application to a  DEAE-ceUulose 
column equilibrated with 0.01  M phosphate buffer, pH  7.5.  Protein solutions were concen- 
trated to 1 per cent and reaction adjusted to pH 9-9.5 by addition of 0.1 N NaOH. Crystalline 
fluoresceine isothincyanate (Baltimore Biological Laboratories, Baltimore)  was  dissolved in 
acetone (2 mg/ml), and added slowly over a  2-hour period to the protein solution with mainte- 
nance of pH 9-9.5 and constant stirring until 10 nag of fluorescein isothiocyanate per gm of 
protein had been added. After reaction was allowed to proceed for 8 hours rapid separation of 
fluorescent globulins from acetone and fluorescent dialyzables was obtained by passing the reac- 
tion mixture through sephadex G-50 columns equilibrated with 0.01 ~  phosphate buffer pH 
7.5. The first fluorescent peak eluted contained both labeled and unlabeled protein in appro- 
priate buffer for rechromatography on DEAE  cellulose to remove non-fluorescent globulin 
molecules. The effluent was placed on a  DEAE  cellulose column equilibrated with 0.01  M 
phosphate buffer pH 7.5 and the elution begun with the same buffer. Fluorescent globulins 
were seen a/fixed to the top of the column and unlabeled protein was eluted. After the effluent 
ceased  to  contain  appreciable  amounts  of  280  m#  absorbing  materials,  the  buffer  was 
changed to 0.01 ~  phosphate in 0.08 ~¢ saline at pH 7.5.  With a  Wood's lamp, a fluorescent 
peak could be seen to separate from the top of the column, travel down, and was collected 
and labeled preparation 1. Buffer was again changed to 0.01 M phosphate in 0.13 M saline at 
pH 7.5 and another peak was seen to separate from the top of the column~ travel down, and 
was collected and labeled preparation 2. 
With this method both non-labeled globulin which blocks specific staining, and heavily 
labeled globulin which causes non-specific staining, are removed. It was not necessary to ab- 
sorb these preparations with liver powders. 
Fixation  and Staining  of Sections.--Organs  to be examined by immunofluorescence were 
removed, quick frozen at  --70°C within I0 minutes after death, and stored  in sealed con- 
tainers at --20°C until frozen sections were prepared. Routinely, sections were obtained from 
kidney, heart, lung, spleen, and liver. Unfixed frozen tissues were cut at a thickness of 5 micra 
in a  eryostat. Sections were fixed by immersion in acetone at room temperatures for 30 min- 
utes and dried in an incubator at 37°C for 30 minutes. Fixation of tissues in alcohol resulted 864  FIBRINOGEN  PRECIPITATION.  II 
in loss of M protein by dissolution as previously reported by Kaplan (4). To a dry section, 
one drop of purified labeled antibody preparation  was added and a slide placed in a moist 
chamber for 45 minutes at 37°C. The sections were then washed with three changes of 0.01 
M  phosphate buffer in saline, pH 7.2, for 5 minutes with gentle agitation on a shaking machine. 
Excess saline buffer was removed and slides mounted with glycerol buffer. 
I-Iistologic sections were also prepared from organs fixed in 10 per cent buffered formalin 
within 10 minutes after sacrifice of the animals, and routinely stained with hematoxylin and 
eosin. In some cases Masson's trichrome and periodic acid-Schiff (PAS) stains were employed. 
Specif~ity of Staining.--Controls  of specificity of staining  with anti-M conjugates consisted 
of the following tests:  (a) conjugates were completely absorbed with homologous partially 
purified M protein;  (b) fluorescent staining was inhibited by prior treatment of slides with 
unlabeled homologous specific antiserum;  and (c) prior treatment with heterologous type- 
specific antisera failed to inhibit fluorescent staining of sections. 
-  The following criteria were met to control specificity of staining with antifibrinogen con- 
jugates: (a) conjugates were completely absorbed with mouse plasma fraction 1; (b) fluorescent 
staining was inhibited by prior treatment of sections with unlabeled absorbed antifibrinogen 
antisera;  and (c) fluorescent staining was not inhibited by prior treatment of sections with 
goat anti-mouse serum antiserum (Hyland Laboratories, Los Angeles, Lot G89). 
Microscopy and Pkotograpky.--The  Zeiss photomicroscopy was equipped with an Osram 
HBO 200 ultraviolet light source, a BG12 exciter filter and a 530 m# barrier filter. Photo- 
graphs were made in color with super anscochrome film, daylight type, and in black and white 
with adox KB14 film. 
Chemical Determinations.--Blood  urea nitrogen  determinations  6 were performed by the 
method of Seligson  and Seligson (15), upon samples, obtained by puncture of the retroorbital 
sinus, which were anficoagulated with heparin, 30 v.s.P, unit/ml. Urinary protein determina- 
tions were performed on samples obtained from rats placed in metabolic cages and collected 
for 18 hours each day from 5 P,J to 11 AM during which time animals drank water ad libitum 
but food was removed. Urines were precipitated with 10 per cent trielfloracetic acid (TCA). 
The precipitate was washed twice with 10 per cent TCA and protein determined by the Lowry 
modification of the Folin-Ciocalteu method using human serum albumin standards (16). 
RESULTS 
Mice were injected intravenously three times within 24 hours with 5 mg per 
injection of Type 1 M protein.  Examination of the organs 24 hours after the 
last injection revealed  lesions in all experimental  animals.  The pleural  space 
contained serosanguineous fluid and hemorrhagic areas were  noted  over  the 
surface of both lungs. The heart, liver, and spleen were grossly normal. Both 
kidneys appeared swollen, pale, and bloodless. Histologic sections of the organs 
revealed several hemorrhagic infarcts of the lungs and occasionally an eosino- 
philic mass  was  seen to  be  occluding a  pulmonary vessel  (Fig.  1).  Striking 
lesions were seen in all sections of the kidneys. Glomeruli were swollen, almost 
filling Bowman's space, and the glomerular capillary bed was completely oc- 
cluded by an eosinophilic amorphous fibrin-like material, shown in Fig. 2. The 
inflammatory reaction  accompanying these  striking lesions  was  slight  with 
occasional  polymorphonuclear leukocytes  and  small  areas  of  necrosis.  The 
tubules were seen to contain proteinaceous material within the lumina but were 
6  Kindly performed under the direction of Dr. David Seligson. FPa~D  S.  KA~rroR  865 
not abnormal. Occasional eosinophilic masses were seen in the spleen and in 
Kupffer's ceils within the liver. Organs of control mice injected with comparable 
amounts of human serum albumin were grossly and microscopically normal 
when examined at intervals from 24 hours to 14 days. A kidney section from a 
control mouse, shown in Fig. 3, was obtained 24 hours after three injections of 
5 mg of HSA; the capillary loops are delicate and contain red blood cells. 
Subsequent  experiments  with  single  intravenous  injections  of  varying 
amounts of M  protein established a  threshold of 3 mg at which renal lesions 
became evident. Ten mice were injected with 3.0 mg of Type I M protein and 
sacrificed in pairs at 1, 2, 4, 8, and 14 days after injection. Sections  from these 
animals revealed lesions only in the kidneys, which were less severe than seen 
previously but were present in nearly all gomeruli. A typical section is shown in 
Fig. 4. The same type of eosinophilic fibrin-like material is seen in portions of 
the glomerulus. Again the inflammatory reaction is slight and necrosis is limited 
to a rare involved area. Glomerular lesions regressed and disappeared within 14 
days. At 3 days the foreign material is still evident (Fig. 5); it became difficult 
to find at 8 days and sections taken at 14 days were indistinguishable from 
controls. 
To determine the nature of the material within the glomerular capillary loops, 
adjacent 5 micra frozen sections were cut from a kidney removed 24 hours after 
the mouse received 8.0 mg of Type 1 M protein intravenously. The first section 
was stained with fluorescent anti-Type 1 M protein antibodies; the next section 
was stained with hematoxylin and eosin, and the third section was prepared 
with fluorescent anti mouse fibrinogen. Figs. 6 a  to 6 c,  demonstrate that the 
eosinophilic material occluding the capillary lumina contains both M  protein 
and  fibrinogen. 
To correlate structural anomalies with changes in renal function, Sprague- 
Dawley rats were intravenously injected with Type 1 M protein (0.1 mg per gm 
of body weight). They were placed in metabolic cages from which urine was 
collected daily, examined microscopically, and tested for protein.  Rats were 
bled by retroorbital sinus puncture performed under light ether anesthesia every 
2 days, and blood-urea-nitrogen levels determined. Two rats were sacrificed on 
day 1, 3,  6, 9,  12,  16, and 23 after M  protein injection; organs were fixed in 
formalin and prepared for histologic section. Examination of heart, liver, lung, 
and spleen sections revealed no abnormalities. Glomerular lesions similar in all 
respects to these observed in mice were noted. A typical rat glomerulus in a sec- 
tion obtained after M protein injection is illustrated in Fig. 7 and may be com- 
pared to a section from a control rat injected with HSA (0.15 mg per gm of body 
weight) shown in Fig. 8. During the first week after M protein injection, pro- 
gressive resolution of glomeruli lesions was apparent. Although small residua 
of M-fibrinogen thrombi were recognizable until the 3rd week, no interruption 
in the gradual improvement of glomerular lesions were noted. However, even 866  FIBRINOGEN  PRECIPITATION.  II 
after recognizable thrombi could not be seen, fine walled glomerular capillaries 
were not common and capillary loops appeared separated by diffuse material 
(Fig. 9). Control rat kidneys never demonstrated significant lesions. 
Urinary protein excretion of rats injected with M  protein increased when 
compared to controls injected with HSA. The highest daily protein output of 
any control rat was 5 mg (Text-fig. 1). On the 1st day after M protein injection 
9 of 26 experimental rats excreted protein in excess of 5 rag/day; in addition 
capillary precipitation tests with type-specific antiserum revealed M protein in 
20 to 26 urines from experimental rats. The number of rats demonstrating ab- 
normal proteinuria  and the degree of abnormality decreased during the  1st 
week, so that on the 7th and 8th days protein excretion of the experimental 
group was comparable to that of controls. An increase during the 2nd week in 
daily proteinuria of some rats in the experimental group was noted; 6 of the 26 
experimental rats excreted ~  5.0 rag/day of protein on days 9 and 10. By the 
end of the 2nd week both groups were again excreting comparable amounts of 
protein. Microscopic examination of the urinary sediments revealed occasional 
casts in the experimental group, but red blood cells or red blood cell casts were 
never seen. 
Elevation of blood urea nitrogen levels in 12 of the 26 experimental rats were 
noted on the 3rd day following  injection of M protein (Text-fig. 2). It should be 
pointed out that both groups were comparable when assayed 24 hours after 
injection. On the 5th day 7 rats in the experimental group had BUN levels above 
30 mg per cent, and on subsequent days levels in experimental animals fell 
within control range. However, on the llth day, 2, and the 13th day, 6 experi- 
mental rats showed modest elevations in BUN. This second rise in BUN levels 
followed the rise in urinary protein levels by 1 to 2 days as did the first elevation 
of BUN levels. 
Capillary precipitin tests performed on rat sera obtained during the experi- 
ment with Type 1 M protein (0.1 mg/ml) demonstrated appearance of anti-M 
antibodies on the 9th day in 20 to 26 experimental animals, including all ani- 
malswith abnormal proteinuria or azotemia. Two more rats demonstrated serum 
anti-M antibodies on the llth day after antigen injection. A typical series of 
precipitin tests on sera from one rat is plotted above the BUN data in Text-fig. 2. 
Review of histologic sections obtained during the early period of the 2nd week 
after M protein injection failed to reveal increased cellularity, inflammation, or 
necrosis to correlate with the observed functional changes. 
DISCUSSION 
The injection of 0.1 mg per gm of body weight of Type 1 M protein into mice 
or rats produced a nephropathy characterized by diffuse eosinophilic glomerular 
lesions shown to contain streptococcal M protein and fibrinogen. The rapidity 
with which M protein reacted with fibrinogen in vitro  (17),  suggests that com- FEED  S.  KANTOR  867 
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plexes were formed intravascularly and then became localized within the glo- 
merular capillary bed. Previous workers have demonstrated the propensity of 
intravenously injected M protein to localize and persist only in the glomerular 
tufts. Although the 0.5 to 1.0 mg amounts injected in their studies were not 
sufficient to produce visible lesions, M protein was detected in glomeruli 4 to 8 
days after injection by Kaplan (4) and 16 days after injection by Miller (18). 
M protein appeared as discrete deposits varying from small particles to large 
globularmasses. Presumably, the unusual distribution of M protein, confined as 
it was, largely within the reticuloendothelial system (RES) and kidney (4), was 
related to its association with fibrinogen forming a macromolecular complex. 
An important question is why M-fibrinogen complexes localize in glomeruli; 
large macromolecules are usually cleared by the RES. Colloidal preparations, 
such as carbon, ordinarily cleared by the RES, may under certain conditions of 
prolonged high blood levels, or endothelial damage, localize outside the RES 
(19). In such situations glomeruli generally show striking accumulation of par. 
ticles. Glomerular damage, as a consequence of retention of circulating colloidal 
material, has been reported after intravenous injection of methyl cellulose and 
saccharated iron oxide (20, 21). 
The histologic picture of the mouse and rat nephropathy produced by injec- 
tion of Type I streptococcal M protein does not resemble human acute diffuse 
glomerulonephritis.  No  hypercellularity and little inflammatory reaction or 
necrosis  was demonstrated. The nephropathy differs also  from that  usually 
produced by antigen-antibody complexes. However, the present renal lesions are 
indistinguishable from glomerular lesions seen in the generalized  Shwartzman 
reaction and those produced by antigen-antibody complexes in animals pre- 
treated with cortisone (22, 23). All three experimental lesions are believed to 
contain fibrinogen or fibrin,  and the similarities  of structure may only reflect 
aggregation of fibrinogen  by endotoxin, by antigen-antibody complexes, and 
by streptococcal M protein in the respective experimental models. 
Proteinuria and urea retention observed after injection of M protein are con- 
sistent with the morphological  glomerular lesions. However, the reappearance 
of proteinuria and mild azotemia  in some rats during the 2nd week coincident  with 
appearance of circulating anti-M antibodies was not accompanied by discernible 
glomerular changes. The persistance of M protein within the glomeruli during 
this period was reported by Miller,  who injected considerably less M protein 
(18). Previous studies have shown that localization  of an antigen within the 
kidney may lead to glomerulonephritis when antibodies develop to that antigen. 
Kay (24), injected duck anti-rabbit kidney serm~ into rabbits but did not ob- 
serve nephritis until anti-duck serum antibodies appeared. Similar results were 
reported by Rothbard and Watson (25) who injected rats with rabbit anti-rat 
collagen antiserum and observed nephritis only when rats were prepared with 
adjuvant and developed anti-rabbit serum antibodies.  In both described in- 870  FIBRINOGEN PRECIPITATION.  II 
instances,  the antigen implicated  in  the  nephritis  was first  localized  in  the 
kidney by viture of its properties as an antibody directed against kidney tissue. 
In the present experiments,  a  different mechanism for the localization  of a 
streptococcal product within the kidney has been demonstrated. Whether the 
complex of M  protein and fibrinogen,  localized  and  concentrated within  the 
glomerulus can stimulate an immune response, thereby inflating glomeruloneph- 
riffs, is unknown. Seegal has recently reported the presence of streptococcal M 
protein in renal glomeruli obtained by biopsy of patients with acute glomerulo- 
nephritis  (26).  Stetson et al.  (27) have observed significant  hematuria during 
the acute streptococcal infection which was prognostic of later development of 
nephritis.  Data presented above raise the suggestion  that intravascular forma- 
tion  of M-fibrinogen  complexes  may cause localization  of M  antigen  in  the 
human kidneys resulting in mild early hematuria. With development of hyper- 
sensitivity  directed  against  previously localized,  persistent  M  protein,  the 
immunologic  reaction would result in acute glomerulonephritis.  This suggestion 
presumes that fibfinogen  will be present in the glomerulus  sometime between 
the onset of infection and the appearance of nephritis.  Opportunity to verify 
this possibility may be provided by examination of human renal tissue which 
has been obtained at the proper time by percutaneous needle biopsy, by surg- 
ical biospy, or by autopsy. 
SUMMARY 
Intravenous injection of Type I streptococcal M protein into mice and rats 
producedlesions confined to renal glomeruli. Thrombi of eosinophilic amorphous 
material, seen to occlude glomerular capillaries,  were shown to contain M pro- 
tein and  fibrinogen.  Gradual  regression  of the morphological  lesions  was ob- 
served during the 3 weeks following injection. Initial abnormal proteinuria and 
azotemia returned to control levels by the end of the 1st week; a second rise in 
urinary protein excretion  and urea retention  was demonstrated  in some rats 
coincident  with  appearance  of  anti-M  antibodies.  The  mechanism  of renal 
localization  of streptococcal M protein by means of a complex with fibrinogen 
was suggested,  which may comprise an initial phase in the pathogenesis of acute 
poststreptococcal glomerulonephritis. 
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EXPLANATION OF  PLATES 
P~  68 
FIG.  1.  Lung,  mouse  12,  injected  with  5.0  mg of Type 1 M  protein  three  times 
within 24 hours,  1 day after last injection. A thrombus occluding a small pulmonary 
vessel contains  eosiniphilic  amorphous material.  Adjacent  lung  appears normal.  X 
400. 
FIG. 2. Kidney, mouse 10, injected with 5 mg of Type 1 M  protein three times within 
24 hours, 1 day after last injection. The glomerular capillary bed is occluded by eosin- 
ophilic amorphous material.  No inflammatory cells  are present and  tubules  appear 
normal.  X 400. 
FIO. 3.  Kidney, mouse 23, injected with 5 mg of HSA three times within 24 hours, 
1 day after last injection. The capillary loops are delicate and open. Bowman's space 
is prominent because glomerulus is not swollen.  X  450. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  68 
(Kantor:  Fibrinogen precipitation. II) PLATE 69 
FIG. 4.  Kidney, mouse 32, injected with 3 mg of Type 1 M  protein, 24 hours after 
injection.  Eosinophilic amorphous  material  within  the  glomerular capillary bed  is 
present but less prominent than in Fig. 2. Little necrosis or inflammatory reaction is 
evident.  X  450. 
FIG. 5.  Kidney, mouse 36, injected with 3 mg of Type  1 M  protein, 3 days after 
injection. Amorphous thrombi of glomerular capillaries are still present but less promi- 
nent. More necrosis of endothelial cells is evident.  X  450. THE  7OURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 121  PLATE  69 
(Kantor:  Fibrinogen precipitation. II) PLATE 70 
Fro. 6  a.  Kidney, mouse 100, injected with 8 mg of Type 1 M  protein, 24 hours 
after  injection. This frozen  section stained with  fluorescent  rabbit  anti-type 1 M 
antiserum. (Preparation  1).  Bright fluorescence  of  the glomerular capillary thrombi 
is evident. ×  250. 
FIG. 6 b.  Kidney, mouse 100, injected with 8 mg of Type 1 M  protein, 24 hours 
after injection. This is an adjacent section to that shown in Figs. 6 a and 6 c, stained 
with hematoxylin and eosin as reference  for glomerular structure.  X  250. 
FIG. 6 c.  Kidney, mouse 100, injected with 8 mg Type 1 M protein, 24 hours after 
injection, stained  with  fluorescent  rabbit  anti-mouse fibrinogen.  (Preparation  1). 
Bright fluorescence of capillary thrombi identifies fibrinogen. X  250. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  121  PLATE  70 
(Kantor:  Fibrinogen precipitation.  -fI) PLATE 71 
FIG. 7.  Kidney, rat 4,  injected with  l0 mg of Type 1 M  protein 24 hours after in- 
jection. Capillary lesions in the glomerulus similar to mouse nephropathy are evident 
but do not involve the entire glomerulus.  ×  250. 
FIG. 8.  Kidney, rat 28, injected with 15  mg of HSA, 24 hours after injection. Glo- 
merular capillary loops are easily visualized. ×  250. 
FIG.  9.  Kidney,  rat 9,  injected with  10  mg of Type  1 M  protein,  16  days after 
injection. No capillary thrombi are recognizable but in the superior pole of each glo- 
merulus, an increase in diffuse intercapillary material is noted.  ×  250. THE JOURNAL  O]~ EXPERIMENTAL  MEDICINE  VOL.  121  PLA~E  71 
(Kantor:  Fibrinogen precipitation.  II) 